HIGHLAND MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $920K
- Transactions
- 257
- Companies
- 22
- Average per transaction
- $3,582
Who reported the payments
| Amgen | $360,205 |
| Merck | $232,478 |
| Beone Medicines USA, Inc. | $57,325 |
| BD | $55,335 |
| Regeneron | $43,871 |
| Incyte Corporation | $31,129 |
| AstraZeneca | $22,419 |
| Johnson & Johnson | $16,751 |
| Diagnostica Stago, Inc | $16,550 |
| KARL Storz Endoscopy-america | $15,171 |
| E.r. Squibb & Sons, L.L.C. | $14,825 |
| Novocure Inc. | $14,650 |
| Pharmacyclics LLC, An Abbvie Company | $14,110 |
| Genentech, Inc. | $9,500 |
| EMD Serono, Inc. | $8,352 |
| Novartis | $3,144 |
| Mindray DS USA, Inc. | $2,599 |
| Boston Scientific | $1,578 |
| Immucor, Inc. | $234 |
| Vero Biotech Inc. | $132 |
| Helsinn Healthcare SA | $127 |
| Astrazeneca UK Limited | $8 |